Genenta Science S.p.A (GNTA) Short-term Investments (2023 - 2025)
Genenta Science S.p.A (GNTA) posted Short-term Investments of $26.3 million for Q4 2025, up 86.22% sequentially from $14.1 million in Q2 2025, and up 205.05% YoY from $8.6 million in Q4 2024.
Genenta Science S.p.A (GNTA) Short-term Investments (2023 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Short-term Investments for 3 years, with the latest figure at $26.3 million in Q4 2025.
- Quarterly Short-term Investments rose 205.05% year-over-year to $26.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.3 million (up 205.05% YoY) and the FY2025 annual result came in at $26.3 million, up 205.05% from the prior year.
- Short-term Investments rose to $26.3 million in Q4 2025 per GNTA's latest filing, from $14.1 million in the prior quarter.
- Over five years, Short-term Investments peaked at $26.3 million in Q4 2025 and troughed at $8.6 million in Q4 2024.
- A 3-year average of $14.6 million and a median of $12.8 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2024 and 2025: Short-term Investments plunged 46.81% in 2024, then soared 205.05% in 2025.
- Over 3 years, Short-term Investments stood at $16.2 million in 2023, then tumbled by 46.81% to $8.6 million in 2024, then jumped by 205.05% to $26.3 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $26.3 million, $14.1 million, and $8.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Genenta Science S.p.A | 25.03 Mn | -34.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.33 Mn |
| Jun 30, 2025 | 14.14 Mn |
| Dec 31, 2024 | 8.63 Mn |
| Jun 30, 2024 | 11.54 Mn |
| Dec 31, 2023 | 16.23 Mn |
| Jun 30, 2023 | 10.89 Mn |